IDYA Stock Analysis: Buy, Sell, or Hold?
IDYA - IDEAYA Biosciences, Inc. Common Stock
$34.10
0.04 (0.12%)
▲
5d:
-1.84%
30d:
+0.74%
90d:
+7.03%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Feb 12, 2026
8d
Get Alerted When IDYA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IDYA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: IDYA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: IDYA is currently trading at $34.10, which is considered slightly low relative to its 30-day fair value range of $33.88 to $36.55.
Technical Outlook: Technically, IDYA is in a strong uptrend. Immediate support is located at $31.62, while resistance sits at $36.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $49.94 (+46.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IDYA is in a strong uptrend. Immediate support is located at $31.62, while resistance sits at $36.70.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $49.94 (+46.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$33.88 -
$36.55
Company Quality Score
46/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.6% below Wall St target ($49.94)
Fair Price Analysis
30-Day Fair Range
$33.88 -
$36.55
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$4.01
(11.8%)
Support & Resistance Levels
Support Level
$31.62
Resistance Level
$36.71
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-9.56
Wall Street Target
$49.94
(+46.6%)
Revenue Growth (YoY)
78.5%
Profit Margin
-74.8%
Last updated: February 03, 2026 9:53 AM ET
Data refreshes hourly during market hours. Next update: 10:53 AM
Data refreshes hourly during market hours. Next update: 10:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IDYA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 61 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 64 BUY |
